Publisher
Springer Science and Business Media LLC
Reference16 articles.
1. Mukherjee, D., Coffey, M. & Maisels, M. J. Frequency and duration of phototherapy in preterm infants <35 weeks gestation. J. Perinatol. 38, 1246–1251 (2018).
2. Hamrick, S. E. G. et al. Patent ductus arteriosus of the preterm infant. Pediatrics 146, e20201209 (2020).
3. Mannan, J. & Amin, S. B. Effect of chest shielding during phototherapy for hyperbilirubinemia on symptomatic patent ductus arteriosus - a double-blind randomized placebo-controlled trial. Pediatr Res. https://doi.org/10.1038/s41390-024-03310-4 (2024). Epub ahead of print.
4. Bhola, K., Foster, J. P. & Osborn, D. A. Chest shielding for prevention of a haemodynamically significant patent ductus arteriosus in preterm infants receiving phototherapy. Cochrane Database Syst. Rev. 11, CD009816 (2015).
5. Mannan, J. & Amin, S. B. Meta-analysis of the effect of chest shielding on preventing patent ductus arteriosus in premature infants. Am. J. Perinatol. 34, 359–363 (2017).